Comparative analysis of oral delivery systems for live rotavirus vaccines

Journal of Controlled Release

Volumn 41, Issue 3, 1996, Pages 237-247

  Duncan, Jacqueline D ^a,d   Wang, Pei Xuan ^a   Harrington, Catherine M ^a   Schafer, Dennis P ^a   Matsuoka, Yumiko ^b   Mestecky, Jiri F ^c   Compans, Richard W ^b   Novak, Miroslav J ^a  

^a Secretech   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Microspheres; Non pareil seeds; Oral delivery systems; Oral vaccination; Rotavirus; Tableting

Indexed keywords

ALGINIC ACID; CELLULOSE; GELATIN; LIVE VACCINE; POLYGLACTIN; ROTAVIRUS VACCINE; STARCH; SUCROSE;

ARTICLE; DRUG COMPARISON; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG STABILITY; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS; TABLET; VIRUS CULTURE;

EID: 0030249112     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01331-4     Document Type: Article

References (21)

1. [1] A.Z. Kapikian and R.M. Chanock. Rotaviruses, in: B.N. Fields and D.M. Knipe (Eds.), Virology, 2nd edn., Raven Press. New York, (1990) pp. 1353-1404.
2. [2] M.S. Ho, R.I. Glass, P.F. Pinsky and L.J. Anderson. Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J. Infect. Dis. 158 (1988) 1112-1116.
3. [3] R.F. Bishop. Development of candidate rotavirus vaccines. Vaccine 11 (1993) 247-254.
4. [4] R.F. Bishop. Epidemiology of diarrheal disease caused by rotavirus, in: J. Holmgren, A. Lindberg and R. Mollby (Eds.), Development of Vaccines and Drugs against Diarrhea. Studentlitteratur, Sweden, (1986) pp. 158-170.
5. [5] J.D. Snyder and M.H. Mersen. The magnitude of the global problem of acute diarrhaeal disease: a review of active surveillance data. Bull. WHO 60 ( 1982) 605 (Abstract).
6. [6] F.T. Saulsbury, J.A. Winkelstein and R.H. Yolken. Chronic rotavirus infection in immunodeficiency. J. Pediat. 97 (1980) 61-65.
7. [7] J. Halvorsrud and I. Orstavik. An epidemic of rotavirus-associated gastroenteritis in a nursing home for the elderly. Scand. J. Infect. Dis. 12 (1980) 161-164.
8. [8] T.J. Marrie, S.H. Lee, R.S. Faulkner. J. Ethier and C.H. Young. Rotavirus infection in a geriatric population. Arch. Intern. Med. 142 (1982) 313-316.
9. [9] H. Holzel, S.W. Cubitt, D.A. McSwiggan, P.J. Sanderson and J. Church. An outbreak of rotavirus infection among adults in a cardiology ward. J. Infect. 2 (1980) 33-37.
10. [10] A.Z. Kapikian and R.M. Chanock. Rotavirus, in: B.N. Fields and D.M. Knipe (Eds.), Virology, 2nd edn., Raven Press, New York. (1985) pp. 863-906.
11. [11] M.K. Estes, D.Y. Graham and B.B. Mason. Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J. Virol. 39 (1981) 879-888.
12. [12] T. Vesikari, E. Isolauri, E. D'Hondt et al. Increased 'take' rate of oral rotavirus vaccine in infants after milk feeding [letter]. Lancet 2 (1984) 700.
13. [13] M.K. Estes, D.Y. Graham, F.M. Smith and C.P. Gerba. Rotavirus stability and inactivation. Gen. Virol. 43 (1979) 403-409.
14. [14] E.L. Palmer, M.L. Martin and F.A. Murphy. Morphology and stability of infantile gastroenteritis virus: comparison with reovirus and bluetongue virus. J. Gen. Virol. 35 (1977) 403-414.
15. [15] A.Z. Kapikian, R.G. Wyatt, M.M. Levine et al. Studies in volunteers with human rotaviruses. Dev. Biol. Stand. 53 (1983) 209.
16. [16] J. Flores, I. Perez-Schael, M. Blanco et al. Reaction to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. J. Clin. Microbiol. 27 (1989) 512-518.
17. [17] N.A. Halsey, E.L. Anderson, S.D. Sears et al. Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children. J. Infect. Dis. 158 (1988) 1261-1267.
18. [18] R. Edelman. Perspective on the development and deployment of rotavirus vaccines [Review]. Pediat. Infect. Dis. J. 6 (1987) 704-710.
19. [19] D.R Cowsar, T.R. Tice, R.M. Gilley and J.P. English. Poly(lactide-co-glycolide) microcapsules for controlled release of steroids. Methods Enzymol. 112 (1985) 101-116.
20. [20] Z. Moldoveanu, M. Novak, Wen-Quiang Huang, R.M. Gilley, J.K. Staas, D.P. Schafer, R.W. Compans and J.F. Mestecky. Oral immunization with influenza virus in biodegradable microspheres. J. Infect. Dis. 167 (1993) 84-90.
21. [21] P.A. Offit, C.A. Khoury, C.A. Moser, H.F. Clark, J.E. Kim and T.J. Speaker. Enhancment of rotavirus immunogenicity by microencapsulation. Virology 203 (1994) 134-143.